1 - 25 of
121
results
for author:"Cook R."
in Literature Citations
| ErbB4 splice variants Cyt1 and Cyt2 differ by 16 amino acids and exert opposing effects on the mammary epithelium in vivo. Muraoka-Cook R.S., Sandahl M.A., Strunk K.E., Miraglia L.C., Husted C., Hunter D.M., Elenius K., Chodosh L.A., Earp H.S. Mol. Cell. Biol. 29:4935-4948(2009) · Mapped (8) |
| Virion incorporation of the herpes simplex virus type 1 tegument protein VP22 occurs via glycoprotein E-specific recruitment to the late secretory pathway. Stylianou J., Maringer K., Cook R., Bernard E., Elliott G. J. Virol. 83:5204-5218(2009) · UniProtKB (4) |
| Nuclear accumulation of e-cadherin correlates with loss of cytoplasmic membrane staining and invasion in pituitary adenomas. Elston M.S., Gill A.J., Conaglen J.V., Clarkson A., Cook R.J., Little N.S., Robinson B.G., Clifton-Bligh R.J., McDonald K.L. J. Clin. Endocrinol. Metab. 94:1436-1442(2009) · Mapped (7) |
| The E3 ubiquitin ligase WWP1 selectively targets HER4 and its proteolytically derived signaling isoforms for degradation. Feng S.M., Muraoka-Cook R.S., Hunter D., Sandahl M.A., Caskey L.S., Miyazawa K., Atfi A., Earp H.S. Mol. Cell. Biol. 29:892-906(2009) · Mapped (3) |
| Prolactin and ErbB4/HER4 signaling interact via Janus kinase 2 to induce mammary epithelial cell gene expression differentiation. Muraoka-Cook R.S., Sandahl M., Hunter D., Miraglia L., Earp H.S. Mol. Endocrinol. 22:2307-2321(2008) · Mapped (13) |
| The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling. Brantley-Sieders D.M., Zhuang G., Hicks D., Fang W.B., Hwang Y., Cates J.M., Coffman K., Jackson D., Bruckheimer E., Muraoka-Cook R.S. et al. J. Clin. Invest. 118:64-78(2008) · Mapped (21) |
| Wnt pathway inhibitors are strongly down-regulated in pituitary tumors. Elston M.S., Gill A.J., Conaglen J.V., Clarkson A., Shaw J.M., Law A.J., Cook R.J., Little N.S., Clifton-Bligh R.J., Robinson B.G. et al. Endocrinology 149:1235-1242(2008) · Mapped (12) |
| Variation of O(6)-methylguanine-DNA methyltransferase (MGMT) promoter methylation in serial samples in glioblastoma. Parkinson J.F., Wheeler H.R., Clarkson A., McKenzie C.A., Biggs M.T., Little N.S., Cook R.J., Messina M., Robinson B.G., McDonald K.L. J. Neurooncol. 87:71-78(2008) · Mapped (3) |
| HER4 D-box sequences regulate mitotic progression and degradation of the nuclear HER4 cleavage product s80HER4. Strunk K.E., Husted C., Miraglia L.C., Sandahl M., Rearick W.A., Hunter D.M., Earp H.S., Muraoka-Cook R.S. Cancer Res. 67:6582-6590(2007) · Mapped (8) |
| Hypersusceptibility to vesicular stomatitis virus infection in Dicer1-deficient mice is due to impaired miR24 and miR93 expression. Otsuka M., Jing Q., Georgel P., New L., Chen J., Mols J., Kang Y.J., Jiang Z., Du X., Cook R. et al. Immunity 27:123-134(2007) · Mapped (6) |
| The HER4 cytoplasmic domain, but not its C terminus, inhibits mammary cell proliferation. Feng S.M., Sartor C.I., Hunter D., Zhou H., Yang X., Caskey L.S., Dy R., Muraoka-Cook R.S., Earp H.S. Mol. Endocrinol. 21:1861-1876(2007) · Mapped (8) |
| Proteomic identification of in vivo substrates for matrix metalloproteinases 2 and 9 reveals a mechanism for resolution of inflammation. Greenlee K.J., Corry D.B., Engler D.A., Matsunami R.K., Tessier P., Cook R.G., Werb Z., Kheradmand F. J. Immunol. 177:7312-7321(2006) · Mapped (14) |
| Heregulin-dependent delay in mitotic progression requires HER4 and BRCA1. Muraoka-Cook R.S., Caskey L.S., Sandahl M.A., Hunter D.M., Husted C., Strunk K.E., Sartor C.I., Rearick W.A. Jr., McCall W., Sgagias M.K. et al. Mol. Cell. Biol. 26:6412-6424(2006) · Mapped (48) |
| The intracellular domain of ErbB4 induces differentiation of mammary epithelial cells. Muraoka-Cook R.S., Sandahl M., Husted C., Hunter D., Miraglia L., Feng S.M., Elenius K., Earp H.S. Mol. Biol. Cell 17:4118-4129(2006) · Mapped (5) |
| Evidence of an oscillating peripheral clock in an equine fibroblast cell line and adipose tissue but not in peripheral blood. Murphy B.A., Vick M.M., Sessions D.R., Cook R.F., Fitzgerald B.P. J. Comp. Physiol. A 192:743-751(2006) · UniProtKB (5) |
| A chondroitin sulfate chain attached to the bone dentin matrix protein 1 NH2-terminal fragment. Qin C., Huang B., Wygant J.N., McIntyre B.W., McDonald C.H., Cook R.G., Butler W.T. J. Biol. Chem. 281:8034-8040(2006) · Mapped (2) |
| The structure of the follistatin:activin complex reveals antagonism of both type I and type II receptor binding. Thompson T.B., Lerch T.F., Cook R.W., Woodruff T.K., Jardetzky T.S. |
| Conditional overexpression of active transforming growth factor beta1 in vivo accelerates metastases of transgenic mammary tumors. Muraoka-Cook R.S., Kurokawa H., Koh Y., Forbes J.T., Roebuck L.R., Barcellos-Hoff M.H., Moody S.E., Chodosh L.A., Arteaga C.L. Cancer Res. 64:9002-9011(2004) · Mapped (3) |
| Human PAD4 regulates histone arginine methylation levels via demethylimination. Wang Y., Wysocka J., Sayegh J., Lee Y.-H., Perlin J.R., Leonelli L., Sonbuchner L.S., McDonald C.H., Cook R.G., Dou Y. et al. |
| Structural requirements for signal transducer and activator of transcription 3 binding to phosphotyrosine ligands containing the YXXQ motif. Shao H., Xu X., Mastrangelo M.A., Jing N., Cook R.G., Legge G.B., Tweardy D.J. J. Biol. Chem. 279:18967-18973(2004) · Mapped (7) |
| Aberrant monocyte prostaglandin synthase 2 (PGS2) expression in type 1 diabetes before and after disease onset. Litherland S.A., She J.X., Schatz D., Fuller K., Hutson A.D., Peng R.H., Li Y., Grebe K.M., Whittaker D.S., Bahjat K. et al. Pediatr Diabetes 4:10-18(2003) · Mapped (4) |
| Multiple human herpesvirus-8 infection. Beyari M.M., Hodgson T.A., Cook R.D., Kondowe W., Molyneux E.M., Scully C.M., Teo C.G., Porter S.R. J. Infect. Dis. 188:678-689(2003) · UniProtKB (146) |
| Hyperconservation of the N-formyl peptide binding site of M3: evidence that M3 is an old eutherian molecule with conserved recognition of a pathogen-associated molecular pattern. Doyle C.K., Davis B.K., Cook R.G., Rich R.R., Rodgers J.R. J. Immunol. 171:836-844(2003) · UniProtKB (92) |
| Evidence for the proteolytic processing of dentin matrix protein 1. Identification and characterization of processed fragments and cleavage sites. Qin C., Brunn J.C., Cook R.G., Orkiszewski R.S., Malone J.P., Veis A., Butler W.T. J. Biol. Chem. 278:34700-34708(2003) · Mapped (1) |
| Systematic discovery of new genes in the Saccharomyces cerevisiae genome. Kessler M.M., Zeng Q., Hogan S., Cook R., Morales A.J., Cottarel G. |
